IL2 and neoplasm: When used as vaccines in both prophylactic and pre-established tumor settings, the IL2-containing TEX were more effective than unmodified TEX or TEX mixed with IL2; CD4+, CD8+, and NK cells were all involved in the anti-tumor immunity [98].